Cargando…

Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway

BACKGROUND: As one of the first steps in the pathology of cerebral ischemia, glutamate-induced excitotoxicity progresses too fast to be the target of postischemic intervention. However, ischemic preconditioning including electroacupuncture (EA) might elicit cerebral ischemic tolerance through amelio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bao-yu, Wang, Guan-ran, Ning, Wen-hua, Liu, Jian, Yang, Sha, Shen, Yan, Wang, Yang, Zhao, Meng-xiong, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542475/
https://www.ncbi.nlm.nih.gov/pubmed/33061951
http://dx.doi.org/10.1155/2020/8840675
_version_ 1783591558673596416
author Zhang, Bao-yu
Wang, Guan-ran
Ning, Wen-hua
Liu, Jian
Yang, Sha
Shen, Yan
Wang, Yang
Zhao, Meng-xiong
Li, Li
author_facet Zhang, Bao-yu
Wang, Guan-ran
Ning, Wen-hua
Liu, Jian
Yang, Sha
Shen, Yan
Wang, Yang
Zhao, Meng-xiong
Li, Li
author_sort Zhang, Bao-yu
collection PubMed
description BACKGROUND: As one of the first steps in the pathology of cerebral ischemia, glutamate-induced excitotoxicity progresses too fast to be the target of postischemic intervention. However, ischemic preconditioning including electroacupuncture (EA) might elicit cerebral ischemic tolerance through ameliorating excitotoxicity. OBJECTIVE: To investigate whether EA pretreatment based on TCM theory could elicit cerebral tolerance against ischemia/reperfusion (I/R) injury, and explore its potential excitotoxicity inhibition mechanism from regulating proapoptotic pathway of the NMDA subtype of glutamate receptor (GluN2B). METHODS: The experimental procedure included 5 consecutive days of pretreatment stage and the subsequent modeling stage for one day. All rats were evenly randomized into three groups: sham MCAO/R, MCAO/R, and EA+MCAO/R. During pretreatment procedure, only rats in the EA+MCAO/R group received EA intervention on GV20, SP6, and PC6 once a day for 5 days. Model preparation for MCAO/R or sham MCAO/R started 2 hours after the last pretreatment. 24 hours after model preparation, the Garcia neurobehavioral scoring criteria was used for the evaluation of neurological deficits, TTC for the measurement of infarct volume, TUNEL staining for determination of neural cell apoptosis at hippocampal CA1 area, and WB and double immunofluorescence staining for expression and the cellular localization of GluN2B and m-calpain and p38 MAPK. RESULTS: This EA pretreatment regime could improve neurofunction, decrease cerebral infarction volume, and reduce neuronal apoptosis 24 hours after cerebral I/R injury. And EA pretreatment might inhibit the excessive activation of GluN2B receptor, the GluN2B downstream proapoptotic mediator m-calpain, and the phosphorylation of its transcription factor p38 MAPK in the hippocampal neurons after cerebral I/R injury. CONCLUSION: The EA regime might induce tolerance against I/R injury partially through the regulation of the proapoptotic GluN2B/m-calpain/p38 MAPK pathway of glutamate.
format Online
Article
Text
id pubmed-7542475
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75424752020-10-13 Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway Zhang, Bao-yu Wang, Guan-ran Ning, Wen-hua Liu, Jian Yang, Sha Shen, Yan Wang, Yang Zhao, Meng-xiong Li, Li Neural Plast Research Article BACKGROUND: As one of the first steps in the pathology of cerebral ischemia, glutamate-induced excitotoxicity progresses too fast to be the target of postischemic intervention. However, ischemic preconditioning including electroacupuncture (EA) might elicit cerebral ischemic tolerance through ameliorating excitotoxicity. OBJECTIVE: To investigate whether EA pretreatment based on TCM theory could elicit cerebral tolerance against ischemia/reperfusion (I/R) injury, and explore its potential excitotoxicity inhibition mechanism from regulating proapoptotic pathway of the NMDA subtype of glutamate receptor (GluN2B). METHODS: The experimental procedure included 5 consecutive days of pretreatment stage and the subsequent modeling stage for one day. All rats were evenly randomized into three groups: sham MCAO/R, MCAO/R, and EA+MCAO/R. During pretreatment procedure, only rats in the EA+MCAO/R group received EA intervention on GV20, SP6, and PC6 once a day for 5 days. Model preparation for MCAO/R or sham MCAO/R started 2 hours after the last pretreatment. 24 hours after model preparation, the Garcia neurobehavioral scoring criteria was used for the evaluation of neurological deficits, TTC for the measurement of infarct volume, TUNEL staining for determination of neural cell apoptosis at hippocampal CA1 area, and WB and double immunofluorescence staining for expression and the cellular localization of GluN2B and m-calpain and p38 MAPK. RESULTS: This EA pretreatment regime could improve neurofunction, decrease cerebral infarction volume, and reduce neuronal apoptosis 24 hours after cerebral I/R injury. And EA pretreatment might inhibit the excessive activation of GluN2B receptor, the GluN2B downstream proapoptotic mediator m-calpain, and the phosphorylation of its transcription factor p38 MAPK in the hippocampal neurons after cerebral I/R injury. CONCLUSION: The EA regime might induce tolerance against I/R injury partially through the regulation of the proapoptotic GluN2B/m-calpain/p38 MAPK pathway of glutamate. Hindawi 2020-09-29 /pmc/articles/PMC7542475/ /pubmed/33061951 http://dx.doi.org/10.1155/2020/8840675 Text en Copyright © 2020 Bao-yu Zhang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Bao-yu
Wang, Guan-ran
Ning, Wen-hua
Liu, Jian
Yang, Sha
Shen, Yan
Wang, Yang
Zhao, Meng-xiong
Li, Li
Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title_full Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title_fullStr Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title_full_unstemmed Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title_short Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway
title_sort electroacupuncture pretreatment elicits tolerance to cerebral ischemia/reperfusion through inhibition of the glun2b/m-calpain/p38 mapk proapoptotic pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542475/
https://www.ncbi.nlm.nih.gov/pubmed/33061951
http://dx.doi.org/10.1155/2020/8840675
work_keys_str_mv AT zhangbaoyu electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT wangguanran electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT ningwenhua electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT liujian electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT yangsha electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT shenyan electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT wangyang electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT zhaomengxiong electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway
AT lili electroacupuncturepretreatmentelicitstolerancetocerebralischemiareperfusionthroughinhibitionoftheglun2bmcalpainp38mapkproapoptoticpathway